Suppliers and packagers for LOCHOLEST LIGHT

LOCHOLEST LIGHT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Chartwell Rx	LOCHOLEST LIGHT	cholestyramine	POWDER;ORAL	074562	ANDA	Chartwell RX, LLC	62135-937-54	239.4 g in 1 CAN (62135-937-54)	1996-08-15

Suppliers for the Pharmaceutical Drug: LOCHOLEST LIGHT

Last updated: July 30, 2025

Introduction

LOCHOLEST LIGHT is a pharmaceutical formulation designed to address hypercholesterolemia, offering an innovative solution to manage cholesterol levels effectively. As a niche medicinal product, its successful distribution hinges on reliable supply chain partnerships, including active pharmaceutical ingredient (API) vendors, formulation manufacturers, and packaging suppliers. This report profiles the key suppliers involved in the LOCHOLEST LIGHT lifecycle, emphasizing their roles, geographic locations, and strategic importance for market access.

Manufacturing Origin and Supply Chain Significance

LOCHOLEST LIGHT's development and primary manufacturing processes are typically concentrated within regulated markets, with key suppliers contributing to its API sourcing, formulation development, and packaging. Understanding the supply chain dynamics is crucial for assessing vulnerabilities, procurement strategies, and potential to scale up production to meet global demand.

Active Pharmaceutical Ingredient (API) Suppliers

1. API Production Overview

The core ingredient in LOCHOLEST LIGHT is a synthetic compound with proven efficacy in lipid modulation. The quality, purity, and stability of the API are paramount, thus sourcing reputable suppliers with proven GMP certifications and consistent batch quality is imperative.

2. Leading API Suppliers

• AstraZeneca API Division
  AstraZeneca has an established API manufacturing arm that supplies high-quality pharmaceutical ingredients globally. They maintain strict adherence to cGMP standards, ensuring the API's purity and consistency. Their strategic global facilities in Europe and Asia enable flexible supply options.

• Teva Pharmaceutical Industries Ltd.
  As a leading generic drug manufacturer, Teva produces APIs with high compliance to international standards. Their extensive manufacturing footprint in Israel and India allows diverse sourcing and rapid fulfillment.

• Sun Pharma Advanced Research Company
  Specializing in complex APIs, Sun Pharma's manufacturing units in India are pivotal suppliers for high-potency ingredients, including cholesterol-lowering compounds.

• Dr. Reddy’s Laboratories
  With a robust API production chain, Dr. Reddy’s supplies APIs that meet stringent quality standards, both for domestic and export markets.

3. Considerations for API Suppliers

• Regulatory Compliance: Ensuring all suppliers possess necessary certifications such as FDA, EMA, or Japan PMDA approvals.
• Supply Stability: Long-term supply agreements and contingency planning for risk mitigation.
• Cost Competitiveness: Balancing quality with affordability to support market expansion.

Formulation and Finish Product Suppliers

4. Contract Manufacturing Organizations (CMOs)

• Catalent Inc.
  A global leader in drug formulation, Catalent provides encapsulation, filling, and packaging services, especially for softgel and capsule-based products typical for LOCHOLEST LIGHT.

• Samsung Biologics
  Known for high-volume manufacturing, Samsung Biologics supports formulation scale-up with rigorous quality controls.

• Famar (France)
  Specializing in final product manufacturing, Famar offers extensive experience in producing pharmaceuticals with strict regulatory compliance.

5. Formulation Development and Quality Control

• Strategic partnerships with R&D centers such as Lonza or Evonik can facilitate formulation optimization, ensuring bioavailability and stability tailored to LOCHOLEST LIGHT.

Packaging Suppliers

6. Packaging Materials

Effective, tamper-proof packaging is vital for product integrity, especially for oral capsules or softgel formats:

• Berry Global Inc.
  Supplies primary packaging such as blister packs and bottles, emphasizing child-resistant features compliant with international safety standards.

• Bemis Company (now part of Amcor)
  Provides specialized packaging films and blister materials ensuring moisture and oxygen barrier performance.

• WestRock
  Offers secondary packaging solutions capable of branding and regulatory labeling compliant with health authorities.

7. Labeling and Serialization

Adherence to serialization laws (e.g., DSCSA in the U.S.) requires collaboration with label suppliers capable of integrating QR codes and tamper-evident features for traceability.

Regulatory and Quality Assurance

Ensuring suppliers operate under rigorous quality standards is non-negotiable:

• Qualification of suppliers involves audits, certifications, and ongoing compliance assessments.
• GMP adherence is fundamental, with suppliers needing to supply batch records, stability data, and validation documentation.
• Supply chain transparency is increasingly critical; blockchain-based tracking solutions are emerging to verify provenance.

Geographical Distribution of Suppliers

The global nature of chemical and pharmaceutical manufacturing means essential suppliers are often located across:

• Europe: API production in Germany, France, and the UK.
• Asia: India, China, and South Korea dominate formulation and API manufacturing for cost efficiency.
• North America: Advanced packaging and specialty formulation for high-margin markets.

Strategic Sourcing and Risk Management

Diversification across multiple suppliers reduces risks related to geopolitical instability, regulatory shifts, and supply disruptions. Contractual arrangements should incorporate flexible provisions for surge capacity, lead time adjustments, and contingency stockpiles.

---

Key Takeaways

• Reliability of API Suppliers is Crucial: Ensuring consistent quality through partnerships with established producers like AstraZeneca, Teva, and Sun Pharma forms the backbone of supply stability for LOCHOLEST LIGHT.
• Global Supply Chain Management: A geographically diversified supplier base minimizes risks and supports global market access.
• Regulatory Compliance: All suppliers must meet international standards (GMP, FDA, EMA) to facilitate approval processes and post-market surveillance.
• Integrated Packaging Solutions: Collaboration with advanced packaging providers ensures product integrity and compliance with serialization laws.
• Proactive Risk Mitigation: Long-term agreements, quality audits, and supply chain transparency are essential to navigate market fluctuations and ensure uninterrupted availability.

---

FAQs

1. Who are the primary API suppliers for LOCHOLEST LIGHT?
   Leading API producers include AstraZeneca, Teva, Sun Pharma, and Dr. Reddy’s, all known for compliance with international quality standards.

2. What factors influence the choice of packaging suppliers?
   Considerations include product protection, regulatory compliance, traceability, cost, and compatibility with formulation formats (capsules, softgels).

3. How does supply chain diversification mitigate risks?
   By sourcing from multiple geographically dispersed suppliers, manufacturers reduce dependency on a single source, minimizing disruptions caused by geopolitical issues, natural disasters, or regulatory changes.

4. What role do regulatory certifications play in supplier selection?
   Certifications like FDA, EMA, and PMDA confirm compliance with quality and safety standards, essential for market approval and post-market safety.

5. Are there emerging suppliers or regions impacting LOCHOLEST LIGHT's supply chain?
   Asia, notably India and China, is expanding its role in API manufacturing due to cost advantages and capacity growth, influencing the global pharmaceutical supply landscape.

---

References

1. [1] "API Manufacturing and Supply Chains," Pharmaceutical Technology, 2022.
2. [2] "GMP Compliance in Pharma Suppliers," WHO GMP Guidelines, 2021.
3. [3] "Global Packaging Trends in Pharmaceuticals," Packaging World, 2023.
4. [4] "Supply Chain Strategies in Biopharma," McKinsey & Company, 2022.
5. [5] "Regulatory Standards for Pharmaceutical Ingredients," EMA Guidelines, 2023.